866-997-4948(US-Canada Toll Free)

Respiratory Assist Devices-Medical Devices Pipeline Assessment, 2020

Published By :

GlobalData

Published Date : Feb 2020

Category :

Medical Equipments

No. of Pages : 85 Pages

Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020" provides an overview of Respiratory Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Incontinence Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Respiratory Assist Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Respiratory Assist Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Respiratory Assist Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Respiratory Assist Devices Overview
3 Products under Development
3.1 Respiratory Assist Devices - Pipeline Products by Stage of Development
3.2 Respiratory Assist Devices - Pipeline Products by Segment
3.3 Respiratory Assist Devices - Pipeline Products by Territory
3.4 Respiratory Assist Devices - Pipeline Products by Regulatory Path
3.5 Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
3.6 Respiratory Assist Devices - Ongoing Clinical Trials
4 Respiratory Assist Devices - Pipeline Products under Development by Companies
4.1 Respiratory Assist Devices Companies - Pipeline Products by Stage of Development
4.2 Respiratory Assist Devices - Pipeline Products by Stage of Development
5 Respiratory Assist Devices Companies and Product Overview
5.1 Advanced Respiratory Technologies LLC Company Overview
5.1.1 Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 ALung Technologies Inc Company Overview
5.2.1 ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Bellco Srl Company Overview
5.3.1 Bellco Srl Pipeline Products & Ongoing Clinical Trials Overview
5.4 Breethe, Inc. Company Overview
5.4.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Case Western Reserve University Company Overview
5.5.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
5.6 enmodes GmbH Company Overview
5.6.1 enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.7 Liberate Medical LLC Company Overview
5.7.1 Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 LivaNova PLC Company Overview
5.8.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Lung Biotechnology PBC Company Overview
5.9.1 Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
5.10 MAQUET Cardiopulmonary AG Company Overview
5.10.1 MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview
5.11 MC3 Inc Company Overview
5.11.1 MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 McGowan Institute for Regenerative Medicine Company Overview
5.12.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview
5.13 Miromatrix Medical Inc Company Overview
5.13.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Pneumedicare Ltd. Company Overview
5.14.1 Pneumedicare Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.15 Rice University Company Overview
5.15.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview
5.16 The Charles Stark Draper Laboratory Inc Company Overview
5.16.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 U.S. Ann Arbor Healthcare System Company Overview
5.17.1 U.S. Ann Arbor Healthcare System Pipeline Products & Ongoing Clinical Trials Overview
5.18 University of Arizona Company Overview
5.18.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
5.19 University of California Los Angeles Company Overview
5.19.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Pittsburgh Company Overview
5.20.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
5.21 X-COR Therapeutics Company Overview
5.21.1 X-COR Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
6 Respiratory Assist Devices- Recent Developments
6.1 Nov 13, 2019: Soleno Therapeutics provides corporate update and reports third quarter 2019 financial results
6.2 Oct 31, 2019: Teleflex reports third quarter 2019 results
6.3 Oct 08, 2019: CardioWise named a top-ten finalist in Best Cardiovascular Digital Diagnostic Category by UCSF Health Hub
6.4 Aug 07, 2019: Inogen announces second quarter 2019 financial results and updates 2019 guidance
6.5 Aug 07, 2019: Soleno Therapeutics provides corporate update and reports second quarter 2019 financial results
6.6 Aug 01, 2019: Teleflex reports second quarter 2019 results
6.7 Jul 11, 2019: ALung announces the achievement of a key milestone in the U.S. based VENT-AVOID trial and continued progress towards completion of the trial
6.8 May 21, 2019: Liberate Medical presents data from its pilot trial of VentFree, a muscle stimulator for mechanically ventilated patients, at the American Thoracic Society 2019 International Conference
6.9 May 13, 2019: Soleno Therapeutics provides corporate update and reports first quarter 2019 financial results
6.10 May 08, 2019: ALung announces that the independent Data and Safety Monitoring Board (DSMB) recommends continuation of VENT-AVOID trial and reports that significant progress continues with their clinical trial programs
6.11 May 07, 2019: Inogen Announces First Quarter 2019 Financial Results and Updates 2019 Guidance
6.12 May 02, 2019: Organ bioprinting gets a breath of fresh air
6.13 May 02, 2019: Teleflex reports first quarter 2019 results
6.14 Apr 29, 2019: Soleno Therapeutics names Gwen A. Melincoff to Board of Directors
6.15 Mar 18, 2019: Soleno Therapeutics provides corporate update and reports fourth quarter and full-year 2018 financial results
6.16 Feb 26, 2019: Inogen announces fourth quarter and full year 2018 financial results and updates 2019 guidance
6.17 Feb 21, 2019: Teleflex reports fourth quarter and full year 2018 results; provides 2019 guidance
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Respiratory Assist Devices - Pipeline Products by Stage of Development
Table 2: Respiratory Assist Devices - Pipeline Products by Segment
Table 3: Respiratory Assist Devices - Pipeline Products by Territory
Table 4: Respiratory Assist Devices - Pipeline Products by Regulatory Path
Table 5: Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
Table 6: Respiratory Assist Devices - Ongoing Clinical Trials
Table 7: Respiratory Assist Devices Companies - Pipeline Products by Stage of Development
Table 8: Respiratory Assist Devices - Pipeline Products by Stage of Development
Table 9: Advanced Respiratory Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Pulmonary Assist Device - Product Status
Table 11: Pulmonary Assist Device - Product Description
Table 12: ALung Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Hattler Catheter - Product Status
Table 14: Hattler Catheter - Product Description
Table 15: Hemolung RAS - Product Status
Table 16: Hemolung RAS - Product Description
Table 17: ULFED - <1L/min - Product Status
Table 18: ULFED - <1L/min - Product Description
Table 19: ULFED - 250 mL/min - Product Status
Table 20: ULFED - 250 mL/min - Product Description
Table 21: ALung Technologies Inc - Ongoing Clinical Trials Overview
Table 22: Hemolung RAS - A Prospective, Multi-center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
Table 23: Hemolung RAS - Enhanced Lung Protective Ventilation with Extracorporeal CO2 Removal During Acute Respiratory Distress Syndrome
Table 24: Hemolung RAS - Evaluation of Clinical Effectiveness of ECCO2R for the Treatment of Patients with Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Table 25: Hemolung RAS - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD
Table 26: Hemolung RAS - HL-CA-1600, Hemolung RAS Registry. A Retrospective Registry Involving Voluntary Reporting of De-identified, Standard of Care Data Following the Commercial Use of the Hemolung Respiratory Assist System (RAS)
Table 27: Hemolung RAS - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure
Table 28: Bellco Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Abylcap - Product Status
Table 30: Abylcap - Product Description
Table 31: Bellco Srl - Ongoing Clinical Trials Overview
Table 32: Abylcap - Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal with the Abylcap System
Table 33: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 34: OXY-1 - Product Status
Table 35: OXY-1 - Product Description
Table 36: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Portable Artificial Lung - Product Status
Table 38: Portable Artificial Lung - Product Description
Table 39: enmodes GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 40: RAS-Q - Product Status
Table 41: RAS-Q - Product Description
Table 42: Liberate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 43: VentFree - Product Status
Table 44: VentFree - Product Description
Table 45: Liberate Medical LLC - Ongoing Clinical Trials Overview
Table 46: VentFree - Breath Synchronized Electrical Stimulation of the Abdominal Wall Muscles to Prevent Respiratory Muscle Atrophy During the Acute Stages of Mechanical Ventilation Therapy
Table 47: VentFree - VentFree: A Novel Abdominal Stimulator to Assist with Ventilator Weaning
Table 48: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Next Generation ECMO System - Product Status
Table 50: Next Generation ECMO System - Product Description
Table 51: Lung Biotechnology PBC Pipeline Products & Ongoing Clinical Trials Overview
Table 52: 3D Bioprinted Lung Transplant - Product Status
Table 53: 3D Bioprinted Lung Transplant - Product Description
Table 54: Implantable Artificial Lung - Product Status
Table 55: Implantable Artificial Lung - Product Description
Table 56: MAQUET Cardiopulmonary AG Pipeline Products & Ongoing Clinical Trials Overview
Table 57: PALP - Product Status
Table 58: PALP - Product Description
Table 59: MC3 Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 60: BioLung - Product Status

List of Figures
Figure 1: Respiratory Assist Devices - Pipeline Products by Stage of Development
Figure 2: Respiratory Assist Devices - Pipeline Products by Segment
Figure 3: Respiratory Assist Devices - Pipeline Products by Territory
Figure 4: Respiratory Assist Devices - Pipeline Products by Regulatory Path
Figure 5: Respiratory Assist Devices - Pipeline Products by Estimated Approval Date
Figure 6: Respiratory Assist Devices - Ongoing Clinical Trials

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *